Laila El Asmar

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Moderna Therapeutics (United States)(Current)

Laila El Asmar is an author at Moderna Therapeutics (United States) specializing in messenger ribonucleic acid (mrna) vaccine formulations, nucleic acid vaccines, and viral vaccines.

Publications per year

2022–2024

Publications

Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial

Christine A. Shaw, Runa Mithani, Archana Kapoor et al. · The Journal of Infectious Diseases · 2024 · 34 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmaceutics +17

234. Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult Cohorts: Results from a Phase 1, Randomized Clinical Trial

Grace Chen, Runa Mithani, Archana Kapoor et al. · Open Forum Infectious Diseases · 2022 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

1–2 of 2